Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy

Anna Rita Bizzarri, Simona Santini, Emilia Coppari, Monica Bucciantini, Silvia Di Agostino, Tohru Yamada, Craig W. Beattie, Salvatore Cannistraro

Research output: Contribution to journalArticlepeer-review

Abstract

p28 is a 28-amino acid peptide fragment of the cupredoxin azurin derived from Pseudomonas aeruginosa that preferentially penetrates cancerous cells and arrests their proliferation in vitro and in vivo. Its antitumor activity reportedly arises from post-translational stabilization of the tumor suppressor p53 normally downregulated by the binding of several ubiquitin ligases. This would require p28 to specifically bind to p53 to inhibit specific ligases from initiating proteosome-mediated degradation. In this study, atomic force spectroscopy, a nanotechnological approach, was used to investigate the interaction of p28 with full-length p53 and its isolated domains at the single molecule level. Analysis of the unbinding forces and the dissociation rate constant suggest that p28 forms a stable complex with the DNA-binding domain of p53, inhibiting the binding of ubiquitin ligases other than Mdm2 to reduce proteasomal degradation of p53.

Original languageEnglish
Pages (from-to)3011-3019
Number of pages9
JournalInternational Journal of Nanomedicine
Volume6
Issue number1
DOIs
Publication statusPublished - 2011

Keywords

  • AFS
  • Cancer physics
  • Unbinding forces

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Organic Chemistry
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy'. Together they form a unique fingerprint.

Cite this